Position in BNTX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$736,397
+$33,001 QoQ
Shares Held
7,914
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#139
of 283 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Freestone Capital Holdings, LLC holds $7,262,289 across 14 Biotechnology names. BNTX ranks #3 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABUS |
Arbutus Biopharma Corp
|
442,500 | $2,124,000 | |
| 2 | IMNM |
Immunome Inc.
|
60,589 | $1,283,880 | |
| 3 | BNTX |
BioNTech SE
This page
|
7,914 | $736,397 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
904 | $563,680 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,004 | $498,716 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
3,700 | $410,811 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,109 | $394,973 | |
| 8 | EXEL |
Exelixis, Inc.
|
6,974 | $379,455 |
All Filings in BNTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $736,397 | 7,914 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $703,396 | 7,914 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $753,412 | 7,914 | Shares | Defined | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||